Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

IBOIBO
3 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in IMPACT BIOMEDICAL INC

Yes. Citadel Advisors holds 49,567 shares of IBO (Impact Biomedical), worth $22,801, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$22,801

Current Shares

49,567

Total Value Change

-$29,673

Total Shares Change

-10,748

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
49,567
-
$22,8010.0%$5.81
29
2025-Q2
Exited
0
-100.0%
$00.0%$8.17
0
2025-Q1
New
60,315
-
$52,4740.0%$10.98
32

Other major holders of IBO: GEODE CAPITAL MANAGEMENT, LLC, VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used